Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$5.11 - $8.76 $20,250 - $34,715
-3,963 Reduced 8.61%
42,039 $364,000
Q4 2023

Feb 15, 2024

BUY
$4.7 - $9.87 $5,903 - $12,396
1,256 Added 2.81%
46,002 $301,000
Q3 2023

Dec 19, 2023

SELL
$9.14 - $12.85 $45,306 - $63,697
-4,957 Reduced 9.97%
44,746 $447,000
Q3 2023

Nov 15, 2023

SELL
$9.14 - $12.85 $45,306 - $63,697
-4,957 Reduced 9.97%
44,746 $447,000
Q2 2023

Dec 19, 2023

SELL
$12.09 - $15.0 $59,120 - $73,350
-4,890 Reduced 8.96%
49,703 $617,000
Q2 2023

Aug 15, 2023

SELL
$12.09 - $15.0 $59,120 - $73,350
-4,890 Reduced 8.96%
49,703 $618,000
Q1 2023

Dec 19, 2023

SELL
$12.99 - $16.48 $22,031 - $27,950
-1,696 Reduced 3.01%
54,593 $764,000
Q1 2023

May 15, 2023

SELL
$12.99 - $16.48 $22,031 - $27,950
-1,696 Reduced 3.01%
54,593 $765,000
Q4 2022

Dec 19, 2023

BUY
$12.5 - $24.78 $144,287 - $286,035
11,543 Added 25.8%
56,289 $805,000
Q4 2022

Feb 15, 2023

BUY
$12.5 - $24.78 $14,762 - $29,265
1,181 Added 2.14%
56,289 $805,000
Q3 2022

Nov 15, 2022

BUY
$20.6 - $30.37 $8,940 - $13,180
434 Added 0.79%
55,108 $1.41 Million
Q2 2022

Aug 15, 2022

SELL
$26.05 - $37.48 $61,425 - $88,377
-2,358 Reduced 4.13%
54,674 $1.55 Million
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $48,626 - $81,348
-1,988 Reduced 3.37%
57,032 $2.01 Million
Q4 2021

Feb 15, 2022

BUY
$35.0 - $45.94 $81,130 - $106,488
2,318 Added 4.09%
59,020 $2.47 Million
Q3 2021

Nov 15, 2021

BUY
$36.8 - $60.62 $501,547 - $826,189
13,629 Added 31.64%
56,702 $2.78 Million
Q2 2021

Aug 16, 2021

BUY
$32.46 - $45.0 $240,171 - $332,955
7,399 Added 20.74%
43,073 $1.8 Million
Q1 2021

May 14, 2021

BUY
$25.8 - $38.49 $920,389 - $1.37 Million
35,674 New
35,674 $1.27 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $723M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.